NCT04620278 2026-01-06
Genetic Investigation of Cancer Predisposition
The University of Texas Health Science Center at San Antonio
Not yet recruiting
Clinical Trials
14 trialsNCT06582108 2024-09-03
ROAR
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting
NCT05111067 2024-08-21
Molecular Subtyping of Triple-negative Breast Cancer and African Ancestry-related Immunogenicity
Nova Scotia Health Authority
Completed
NCT05605379 2024-08-14
CML Piramid
University Hospital, Bordeaux
Recruiting
NCT03474614 2024-04-19
Effect of Oral Propranolol on mRNA Expresssion in Symptomatic Cavernous Malformation
St. Joseph's Hospital and Medical Center, Phoenix
Phase 2 Terminated
NCT05390112 2022-05-25
Mona-Lisa
University Hospital, Rouen
Unknown
NCT04105374 2020-03-24
Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma
NRG Oncology
Phase 2/3 Withdrawn
NCT04215913 2020-01-02
PSC
Shanghai 10th People's Hospital
Unknown
NCT00793208 2019-04-12
Immunization of Patients With Non Small Cell Lung Cancer (NSCLC)
University of Pittsburgh
Phase 1 Terminated
NCT00984035 2018-09-11
Investigation of Cisplatin-Related Kidney Toxicity
University of Chicago
Completed
NCT02211027 2017-09-07
Biological Vaccine: Semi-allogeneic Human Fibroblasts (MRC-5) Transfected With DNA
University of Pittsburgh
Phase 1 Withdrawn
NCT00377247 2016-07-11
Active Immunization of Patients With Carcinoma of Oral Cavity or Oropharynx With Autologous Dendritic Cells Transfected With DNA From Autologous Tumor
University of Pittsburgh
Phase 1 Terminated
NCT00898742 2013-04-02
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
Vanderbilt-Ingram Cancer Center
Terminated
NCT00566566 2007-12-03
Adipokines as Predictors of the Metabolic Syndrome in ALL Survivors
Sheba Medical Center
Unknown